1
|
Scherdel P, Taine M, Bergerat M, Werner A, Breton JL, Polak M, Linglart A, Reynaud R, Frandji B, Carel JC, Brauner R, Chalumeau M, Heude B. New French height velocity growth charts: An innovative big-data approach based on routine measurements. Acta Paediatr 2024. [PMID: 39315704 DOI: 10.1111/apa.17433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/31/2023] [Revised: 09/03/2024] [Accepted: 09/10/2024] [Indexed: 09/25/2024]
Abstract
AIM Height velocity is considered a key auxological tool to monitor growth, but updated height velocity growth charts are lacking. We aimed to derive new French height velocity growth charts by using a big-data approach based on routine measurements. METHODS We extracted all growth data of children aged 1 month-18 years from the electronic medical records of 42 primary care physicians, between 1 January 1990 and 8 February 2018, throughout the French metropolitan territory. We derived annual and biannual height velocity growth charts until age 15 years by using the Lambda-Mu-Sigma method. These new growth charts were compared to the 1979 French and 2009 World Health Organisation (WHO) ones. RESULTS New height velocity growth charts were generated with 193 124 and 209 221 annual and biannual values from 80 204 and 87 260 children, respectively, and showed good internal fit. Median curves were close to the 1979 French or 2009 WHO ones, but SD curves displayed important differences. Similar results were found with the biannual height velocity growth charts. CONCLUSION We produced new height velocity growth charts until age 15 years by using a big-data approach applied to measurements routinely collected in clinical practice. These updated growth charts could help optimise growth-monitoring performance.
Collapse
Affiliation(s)
- Pauline Scherdel
- Inserm, Center for Research in Epidemiology and StatisticS (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Université Paris Cité, Paris, France
| | - Marion Taine
- Inserm, Center for Research in Epidemiology and StatisticS (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Université Paris Cité, Paris, France
| | - Manon Bergerat
- Department of General Pediatrics and Pediatric Infectious Diseases, AP-HP, Necker-Enfants malades hospital, Université Paris Cité, Paris, France
| | - Andreas Werner
- Association Française de Pédiatrie Ambulatoire, Commission Recherche, Pediatric office, Villeneuve-lès-Avignon, France
| | - Julien Le Breton
- Département universitaire de médecine générale, F-94010 Créteil, Univ Paris Est Créteil, INSERM, IMRB, CEpiA Team, F-94010 Créteil, Univ Paris Est Créteil, Société Française de Médecine Générale (SFMG), F-92130 Issy-les-Moulineaux, Centre de santé universitaire Salvador Allende, La Courneuve, France
| | - Michel Polak
- Department of Pediatric Endocrinology, Gynecology, and Diabetology, AP-HP, Necker-Enfants malades hospital, Université Paris Cité, Paris, France
| | - Agnès Linglart
- Department of endocrinology and diabetology for children, AP-HP, INSERM, Research unit Physiologie physiopathologie endocrinienne, CHU Bicêtre Paris Saclay, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France
| | - Rachel Reynaud
- Pediatric multidisciplinary department, Endocrinology and diabetology unit, APHM, MMG, U 1251, Aix Marseille Univ-INSERM, Marseille, France
| | | | - Jean-Claude Carel
- Department of Pediatric Endocrinology and Diabetology, Reference Center for Growth and Development Endocrine Diseases, AP-HP, Robert-Debré hospital, Université Paris Cité, Paris, France
| | - Raja Brauner
- Pediatric Endocrinology unit, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
| | - Martin Chalumeau
- Inserm, Center for Research in Epidemiology and StatisticS (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Université Paris Cité, Paris, France
- Department of General Pediatrics and Pediatric Infectious Diseases, AP-HP, Necker-Enfants malades hospital, Université Paris Cité, Paris, France
| | - Barbara Heude
- Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Université Paris Cité, Paris, France
| |
Collapse
|
2
|
Sabinkar G, Sabinkar B, Sarathi V, Kumar DK. Growth Velocity in South Indian Children Between Three and 18 Years of Age. Cureus 2023; 15:e50865. [PMID: 38249282 PMCID: PMC10799202 DOI: 10.7759/cureus.50865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/20/2023] [Indexed: 01/23/2024] Open
Abstract
Objective Height velocity is a crucial anthropometric parameter for the evaluation of mild- or recent-onset short stature; however, there is no data on height velocity in South Indian children. We undertook this study to establish the normative data. Methods This prospective longitudinal study included 3327 apparently healthy children aged three to 18 years from government and private schools of Krishna district, Andhra Pradesh. Height and weight were measured at baseline and three-monthly intervals for one year (October 2018 to October 2019). Results Age- and sex-specific height velocity percentiles were generated. The data was available in 1627 boys and 1700 girls. The mean peak height velocity (PHV) was 7.18±2.56 cm in boys observed at 12-12.9 years and 5.8±2.56 cm in girls at 10-10.9 years. Conclusion Normative height velocity data for South Indian children has been presented.
Collapse
Affiliation(s)
- Gayatri Sabinkar
- Endocrinology and Metabolism, All India Institute of Medical Sciences, Bibinagar, Hyderabad, IND
| | - Babulal Sabinkar
- Pulmonary Medicine, Nimra Institute of Medical Sciences, Vijayawada, IND
| | - Vijaya Sarathi
- Endocrinology and Diabetes, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, IND
| | - Dileep K Kumar
- Endocrinology, Narayana Medical College and Hospital, Nellore, IND
| |
Collapse
|
3
|
A Mixed-Longitudinal Study of Height Velocity of Greek Schoolchildren and the Milestones of the Adolescent Growth Spurt. CHILDREN 2022; 9:children9060790. [PMID: 35740727 PMCID: PMC9221559 DOI: 10.3390/children9060790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/05/2022] [Revised: 05/18/2022] [Accepted: 05/25/2022] [Indexed: 12/04/2022]
Abstract
Height velocity (HV) growth charts constructed from longitudinal studies are scarce as they have inherent difficulties, e.g., time, and costs. These difficulties can be partly overcome by a mixed-longitudinal study that covers the entire age range within 3–6 years. To construct HV charts of Greek children and to estimate the milestones of the adolescent growth spurt (AGS), i.e., the onset of AGS (take-off), peak HV, and total pubertal growth (TPG), we performed a mixed longitudinal study in 1514 Greek schoolchildren (6–18 years) with height measurements every 6 months during three schoolyears. We constructed HV charts for boys and girls. Take-off occurs earlier in girls, and, in both sexes, it precedes by 1–1.5 years the appearance of physical signs of puberty. PHV in boys occurs at 12.61 years and in girls at 10.93 years. At take-off, boys are 5 cm taller than girls and TPG for boys is 35.8 cm and for girls 27.3 cm. We constructed HV charts plotted by age, irrespective of pubertal status, and presented data on the milestones of AGS. Furthermore, we suggest that the gradual increase in IGF-1 and E2 that occurs after 5 to 6 years of age triggers the onset of AGS, which precedes physical signs of puberty.
Collapse
|
4
|
Zhou H, Li S, Wang X, Chen Z, Zhang L, Shao L, Tian Y, Yu J, Zheng C, Chen L, Cao X, Wang Z. The prevalence of hypertension in Chinese adolescents aged 15-17 years: A comparison of different criteria. J Clin Hypertens (Greenwich) 2022; 24:378-384. [PMID: 35297171 PMCID: PMC8989742 DOI: 10.1111/jch.14462] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2022] [Revised: 02/14/2022] [Accepted: 02/28/2022] [Indexed: 11/29/2022]
Abstract
This study intended to compare the prevalence of hypertension in adolescents aged 15–17 years in China according to different criteria defined by various guidelines. We included 28 715 adolescents aged 15–17 years from the China Hypertension Survey study (CHS) 2012–2015, and the 2017 American Association of Pediatrics (AAP) Clinical Practice Guideline and 2018 Chinese guidelines for children and adults were used to define hypertension. The prevalence of hypertension among Chinese adolescents aged 15–17 years was 24.4% according to the 2018 Chinese guidelines for children; the corresponding values were 18.6% according to the 2017 AAP Guidelines, and 3.5% according to 2018 Chinese guidelines for adults. The age‐specific prevalence of hypertension in the age of 15, 16, and 17 years in the same population was 26.2%, 24.4%, and 23.3% according to 2018 Chinese guidelines for children; 18.8%, 17.9%, and 19.2% as per the 2017 AAP Guidelines; 3.4%, 3.4%, and 3.6% as per the 2018 Chinese guidelines for adults. A highest prevalence of hypertension was observed according to 2018 Chinese guidelines for children than the other two guidelines. Compared with the 2018 Chinese guidelines for children, a higher 95th percentile BP (systolic and diastolic) was also observed in the present study in each gender‐age‐height‐specific group. And the height, which was key factor to influence blood pressure, was similar between adolescents aged 15–17 and adults, and a paralleled result was seen in the present study. Therefore, the 2018 Chinese guidelines for adults may also be appropriate for adolescents aged 15–17 years.
Collapse
Affiliation(s)
- Haoqi Zhou
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Suning Li
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Xin Wang
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Zuo Chen
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Linfeng Zhang
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Lan Shao
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Ye Tian
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Jing Yu
- Department of Cardiology, Lanzhou University Second Hospital, Gansu, China
| | - Congyi Zheng
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Lu Chen
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Xue Cao
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| | - Zengwu Wang
- Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular, Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China
| |
Collapse
|
5
|
陈 曼, 杨 招, 苏 彬, 李 艳, 高 迪, 马 莹, 马 涛, 董 彦, 马 军. [Analysis on the law of height growth spurt in adolescence of children and adolescents in Zhongshan City]. BEIJING DA XUE XUE BAO. YI XUE BAN = JOURNAL OF PEKING UNIVERSITY. HEALTH SCIENCES 2021; 53:506-510. [PMID: 34145852 PMCID: PMC8220054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 12/28/2020] [Indexed: 08/13/2024]
Abstract
OBJECTIVE To analyze the characteristics of the age at peak height velocity and peak height velocity of primary and middle school students in Zhongshan City, Guangdong Province, and to explore the law of the sudden increase in adolescent height in this area, and to understand the law of height growth spurt in adolescence by longitudinal tracking of the height of children and adolescents in Zhong-shan City. METHODS Based on the physical examination database of primary and middle school students in Zhongshan City, Guangdong Province from 2005 to 2016, individuals who had been continuously tracked for more than 6 times were selected as research samples. SITAR model was used to fit the height data of the sample population, and the age at peak height velocity and peak height velocity were calcula-ted. RESULTS A total of 49 579 subjects were included in this study, including 26 524 boys and 26 008 urban students. The median follow-up ages of boys and girls were 7.74 and 7.72 years, respectively. The boy's height spurt peak age was (12.72±0.89) years, and later than the girls at the age of (10.98±0.95) years (t=207.639, P < 0.001), the boy's height spurt peak velocity of (10.12±1.49) cm/year, higher than the girls of (8.35±1.12) cm/year (t=150.826, P < 0.001). The gender differences of height spurt peak age and height spurt peak speed in urban and rural students were consistent with the whole sample. The height surge peak age of urban male students was earlier than that of rural male students, and the height surge peak speed of urban female students was lower than that of rural female students. CONCLUSION The peak age of the surge of girls was earlier than that of boys, but the peak rate of the surge of girls was lower than that of boys, the peak age of urban students was earlier than that of rural students, but the peak rate of urban boys was lower than that of rural boys in Guangdong Province.
Collapse
Affiliation(s)
- 曼曼 陈
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 招庚 杨
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 彬彬 苏
- 北京大学人口研究所,北京 100871Institute of Population Research, Peking University, Beijing 100871, China
| | - 艳辉 李
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 迪 高
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 莹 马
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 涛 马
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 彦会 董
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 军 马
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| |
Collapse
|
6
|
陈 曼, 杨 招, 苏 彬, 李 艳, 高 迪, 马 莹, 马 涛, 董 彦, 马 军. [Analysis on the law of height growth spurt in adolescence of children and adolescents in Zhongshan City]. BEIJING DA XUE XUE BAO. YI XUE BAN = JOURNAL OF PEKING UNIVERSITY. HEALTH SCIENCES 2021; 53:506-510. [PMID: 34145852 PMCID: PMC8220054 DOI: 10.19723/j.issn.1671-167x.2021.03.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 12/28/2020] [Indexed: 06/12/2023]
Abstract
OBJECTIVE To analyze the characteristics of the age at peak height velocity and peak height velocity of primary and middle school students in Zhongshan City, Guangdong Province, and to explore the law of the sudden increase in adolescent height in this area, and to understand the law of height growth spurt in adolescence by longitudinal tracking of the height of children and adolescents in Zhong-shan City. METHODS Based on the physical examination database of primary and middle school students in Zhongshan City, Guangdong Province from 2005 to 2016, individuals who had been continuously tracked for more than 6 times were selected as research samples. SITAR model was used to fit the height data of the sample population, and the age at peak height velocity and peak height velocity were calcula-ted. RESULTS A total of 49 579 subjects were included in this study, including 26 524 boys and 26 008 urban students. The median follow-up ages of boys and girls were 7.74 and 7.72 years, respectively. The boy's height spurt peak age was (12.72±0.89) years, and later than the girls at the age of (10.98±0.95) years (t=207.639, P < 0.001), the boy's height spurt peak velocity of (10.12±1.49) cm/year, higher than the girls of (8.35±1.12) cm/year (t=150.826, P < 0.001). The gender differences of height spurt peak age and height spurt peak speed in urban and rural students were consistent with the whole sample. The height surge peak age of urban male students was earlier than that of rural male students, and the height surge peak speed of urban female students was lower than that of rural female students. CONCLUSION The peak age of the surge of girls was earlier than that of boys, but the peak rate of the surge of girls was lower than that of boys, the peak age of urban students was earlier than that of rural students, but the peak rate of urban boys was lower than that of rural boys in Guangdong Province.
Collapse
Affiliation(s)
- 曼曼 陈
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 招庚 杨
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 彬彬 苏
- 北京大学人口研究所,北京 100871Institute of Population Research, Peking University, Beijing 100871, China
| | - 艳辉 李
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 迪 高
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 莹 马
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 涛 马
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 彦会 董
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| | - 军 马
- 北京大学公共卫生学院,北京大学儿童青少年卫生研究所,北京 100191Institute of Child and Adolescent Health, Peking University School of Public Health, Beijing 100191, China
| |
Collapse
|
7
|
Dutta P, Reddy KS, Rai A, Madugundu AK, Solanki HS, Bhansali A, Radotra BD, Kumar N, Collier D, Iacovazzo D, Gupta P, Raja R, Gowda H, Pandey A, Devgun JS, Korbonits M. Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child. J Clin Endocrinol Metab 2019; 104:3539-3544. [PMID: 31125088 PMCID: PMC6619489 DOI: 10.1210/jc.2019-00432] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Accepted: 05/20/2019] [Indexed: 12/21/2022]
Abstract
CONTEXT Inactivating germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene are linked to pituitary adenoma predisposition. Here, we present the youngest known patient with AIP-related pituitary adenoma. CASE DESCRIPTION The patient presented at the age of 4 years with pituitary apoplexy and left ptosis with severe visual loss following a 1-year history of abdominal pain, headaches, and rapid growth. His IGF-1 level was 5× the upper limit of normal, and his random GH level was 1200 ng/mL. MRI showed a 43 × 24 × 35‒mm adenoma with suprasellar extension invading the left cavernous sinus (Knosp grade 4). After transsphenoidal surgery, histology showed a grade 2A sparsely granulated somatotropinoma with negative O6-methylguanine-DNA methyltransferase and positive vascular endothelial growth factor staining. Genetic testing identified a heterozygous germline nonsense AIP mutation (p.Arg81Ter). Exome sequencing of the tumor revealed that it had lost the entire maternal chromosome-11, rendering it hemizygous for chromosome-11 and therefore lacking functional copies of AIP in the tumor. He was started on octreotide, but because the tumor rapidly regrew and IGF-1 levels were unchanged, temozolomide was initiated, and intensity-modulated radiotherapy was administered 5 months after surgery. Two months later, bevacizumab was added, resulting in excellent tumor response. Although these treatments stabilized tumor growth over 4 years, IGF-1 was normalized only after pegvisomant treatment, although access to this medication was intermittent. At 3.5 years of follow-up, gamma knife treatment was administered, and pegvisomant dose increase was indicated. CONCLUSION Multimodal treatment with surgery, long-acting octreotide, radiotherapy, temozolomide, bevacizumab, and pegvisomant can control genetically driven, aggressive, childhood-onset somatotropinomas.
Collapse
Affiliation(s)
- Pinaki Dutta
- Department of Endocrinology, Postgraduate Institution of Medical Education and Research, Chandigarh, India
| | - Kavita S Reddy
- Institute of Bioinformatics, International Tech Park, Bangalore, Karnataka, India
| | - Ashutosh Rai
- Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India
| | - Anil K Madugundu
- Institute of Genetic Medicine, Division of Proteomics, Mayo Clinic, Rochester, Minnesota
- Manipal Academy of Higher Education, Manipal, Karnataka, India
- Center for Individualized Medicine and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
| | - Hitendra S Solanki
- Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India
- School of Biotechnology, KIIT University, Bhubaneswar, India
| | - Anil Bhansali
- Department of Endocrinology, Postgraduate Institution of Medical Education and Research, Chandigarh, India
| | - Bishan D Radotra
- Department of Histopathology, Postgraduate Institution of Medical Education and Research, Chandigarh, India
| | - Narendra Kumar
- Department of Radiotherapy, Postgraduate Institution of Medical Education and Research, Chandigarh, India
| | - David Collier
- Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom
| | - Donato Iacovazzo
- Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom
| | | | - Remya Raja
- Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India
| | - Harsha Gowda
- Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India
| | - Akhilesh Pandey
- Institute of Genetic Medicine, Division of Proteomics, Mayo Clinic, Rochester, Minnesota
- Center for Individualized Medicine and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
| | - Jagtar Singh Devgun
- Department of Pathology, Maharishi Markandeshwar Institute of Medical Science and Research, Ambala, Haryana, India
| | - Márta Korbonits
- Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom
- Correspondence and Reprint Requests: Márta Korbonits, MD, PhD Centre for of Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom. E-mail:
| |
Collapse
|
8
|
|
9
|
|